Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells

Biochemical Pharmacology

Volumn 59, Issue 11, 2000, Pages 1477-1487

  De Nigris, Filomena ^a,c   Franconi, Flavia ^c   Maida, Ivana ^c   Palumbo, Giuseppe ^b   Anania, Vittorio ^c   Napoli, Claudio ^a,c,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

tocopherol; tocopherol; Apoptosis, SMC; CHD; LDL; Oxidation

Indexed keywords

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTERY WALL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY; DRUG MECHANISM; HEART PROTECTION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ADULT; APOPTOSIS; CELLS, CULTURED; CORONARY VESSELS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; LIPOPROTEINS, LDL; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; VITAMIN E;

EID: 0034213087     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00275-6     Document Type: Article

References (61)

1. Kockx M.M. Apoptosis in the atherosclerotic plaque Quantitative and qualitative aspects . Arterioscler Thromb Vasc Biol. 18:1998;1519-1522.
2. Reid V.C., Mitchinson M.J., Skepper J.N. Cytotoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages An ultrastructural study . J Pathol. 171:1993;321-328.
3. Escargueil-Blanc I., Salvayre R., Negre-Salvayre A. Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells. FASEB J. 8:1994;1075-1080.
4. Mallat Z., Ohan J., Leseche G., Tedgui A. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 96:1997;424-428.
5. Bjorkerud B., Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol. 16:1996;416-424.
6. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 272:1997;20963-20966.
7. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 100:1997;2680-2690.
8. Napoli C., Glass C.K., Witztum J.L., Deutch R., D'Armiento F.P., Palinski W. Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood Fate of Early Lesions in Children (FELIC) study . Lancet. 354:1999;1234-1241.
9. Burton G.W., Joyce A., Ingold K.U. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human plasma and erythrocyte membrane? Arch Biochem Biophys. 221:1993;281-290.
10. Behrens W.A., Madere R. Alpha- and gamma tocopherol concentrations in human serum. J Am Coll Nutr. 5:1986;91-96.
11. Tran K., Chan A.C. Comparative uptake of alpha- and gamma-tocopherol by human endothelial cells. Lipids. 27:1992;38-41.
12. Spencer A.P., Carson D.S., Crouch M.A. Vitamin E and coronary artery disease. Arch Intern Med. 159:1999;1313-1320.
13. Stephens N.G., Parsons A., Schoffield P.M., Kelly F., Cheesman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease Cambridge Heart Antioxidant Study (CHAOS) . Lancet. 347:1996;781-786.
14. Riemersma R.A., Wood D.A., Macintyre C.C., Elton R.A., Gey K.F., Oliver M.F. Risk of angina pectoris and plasma concentration of vitamins A, C, E and carotene. Lancet. 337:1991;1-5.
15. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1993;1450-1456.
16. Stampfer M.J., Hennekens C.H., Manson G.A., Colditz G.A., Brosner B., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med. 328:1993;1444-1449.
17. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 334:1996;1156-1162.
18. Ohrvall M., Sundlof G., Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med. 239:1996;111-117.
19. Keaney J.F. Jr, Simon D.I., Freedman J.E. Vitamin E and vascular homeostasis implications for atherosclerosis . FASEB J. 13:1999;965-976.
20. Dimmeler S., Haendeler J., Galle J., Zeiher A.M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the "response to injury" hypothesis. Circulation. 95:1997;1760-1763.
21. Aravind L., Dixit V.M., Koonin E.V. The domains of death Evolution of the apoptosis machinery . Trends Biochem Sci. 24:1999;47-53.
22. Widmann C., Gerwins P., Johnson N.L., Jarpe M.B., Johnson G.L. MEK-kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol. 18:1998;1-13.
23. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol. 11:1999;211-218.
24. Mercurio F., Manning A.M. Multiple signals converging on NF-kB. Curr Opin Cell Biol. 11:1999;226-232.
25. Napoli C., Mancini F.P., Corso G., Malorni A., Crescenzi E., Postiglione A., Palumbo G. A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a). J Biochem. 121:1997;1096-1101.
26. Lowry O.H., Rosebrough H.J., Farr A.L., Randall R.J. Protein measurement with the folin-phenol reagent. J Biol Chem. 193:1951;265-275.
27. Napoli C., Chiariello M., Palumbo G., Ambrosio G. Calcium channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals. Cardiovasc Drugs Ther. 10:1996;417-424.
28. Liguori A., Casini A., Di Loreto M., Andreini I., Napoli C. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure. Eur J Clin Pharmacol. 55:1999;117-124.
29. Wu C. An exonuclease protection assay reveals heat-shock element and TATA box DNA-binding proteins in crude nuclear extracts. Nature. 317:1985;84-87.
30. Zimarino V., Wu C. Induction of sequence-specific binding of Drosophila heat-shock activator protein without protein synthesis. Nature. 327:1987;727-730.
31. Harlow E., Lane D. Immunoblotting A Laboratory Manual . 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
32. Yi H.K., Fujimura Y., Ouchida M., Prasad D.D., Rao V.N., Reddy E.S. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene. 14:1997;1259-1268.
33. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
34. Tortora G., Pepe S., Bianco C., Baldassarre G., Budillon A., Clair T., Cho-Chung Y.S., Bianco A.R., Ciardiello F. The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene. 9:1994;3233-3240.
35. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 92:1995;7686-7689.
36. Wan Y., Bence K., Hata A., Kurosaki T., Veillette A., Huang X.Y. Genetic evidence for a tyrosine kinase cascade preceding the mitogen-activated protein kinase cascade in vertebrate G protein signaling. J Biol Chem. 272:1997;17209-17215.
37. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035, 1994.
38. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Yang C.S., Zheng S.F., Gail M., Li G., et al. Nutrition intervention trials in Linxian, China supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population . J Natl Cancer Inst. 85:1993;1483-1492.
39. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354: 447-455, 1999.
40. Hercberg S., Galan P., Preziosi P., Alfarez M.J., Vasquez C. The potential role of antioxidant vitamins in preventing cardiovascular disease and cancers. Nutrition. 14:1998;513-520.
41. Lonn E.M., Yusuf S. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data. Can J Cardiol. 13:1997;957-965.
42. Esterbauer H., Puhl H., Dieber-Rotheneder M., Waeg G., Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann Med. 23:1991;573-581.
43. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., Mordan L.J. Gamma-tocopherol detoxification of nitrogen dioxide Superiority to alpha-tocopherol . Proc Natl Acad Sci USA. 90:1993;1771-1775.
44. Ushakova T., Melkonyan H., Nikonova L., Afanasyev V., Gaziev A.I., Mudrik N., Bradbury R., Gogvadze V. Modification of gene expression by dietary antioxidants in radiation-induced apoptosis of mice splenocytes. Free Radic Biol Med. 26:1999;887-891.
45. Handelman G.J., Machlin L.J., Fitch K., Weiter J.J., Dratz E.A. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr. 115:1985;807-813.
46. Suarna C., Dean R.T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 15:1995;1616-1624.
47. Boscoboinik D., Szewczyk A., Hensey C., Azzi A. Inhibition of cell proliferation by alpha-tocopherol. J Biol Chem. 266:1991;6188-6194.
48. Deigner H.P., Claus R. Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells. FEBS Lett. 385:1996;149-153.
49. Kusuhara M., Chait A., Cader A., Berk B.C. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 17:1997;141-148.
50. Auge N., Escargueil-Blanc I., Lajoie-Mazenc I., Suc I., Andrieu-Abadie N., Pieraggi M.T., Chatelut M., Thiers J.C., Jaffrezou J.P., Laurent G., Levade T., Negre-Salvayre A., Salvayre R. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J Biol Chem. 273:1998;12893-12900.
51. Srivastava R.K., Mi Q.S., Hardwick J.M., Longo D.L. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci USA. 96:1999;3775-3780.
52. Allen M.P., Zeng C., Schneider K., Xiong X., Meintzer M.K., Bellosta P., Basilico C., Varnum B., Heidenreich K.A., Wierman M.E. Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadoprin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol. 13:1999;191-201.
53. Petrache I., Choi M.E., Otterbein L.E., Chin B.Y., Mantell L.L., Horowitz S., Choi A.M. Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. Am J Physiol. 277:1999;L589-L595.
54. van den Brink M.R., Kapeller R., Pratt J.C., Chang J.H., Burakoff S.J. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem. 274:1999;11178-11185.
55. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:1998;4426-4441.
56. Basu S., Kolesnick R. Stress signals for apoptosis Ceramide and c-Jun kinase . Oncogene. 17:1998;3277-3285.
57. Rao G.N., Katki K.A., Madamanchi N.R., Wu Y., Birrer M.J. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells. J Biol Chem. 274:1999;6003-6010.
58. Abe J.I., Bradford C.B. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med. 8:1998;59-64.
59. Hamilton T.A., Major J.A., Armstrong D., Tebo J.M. Oxidized LDL modulates activation of NFKappaB in mononuclear phagocytes by altering the degradation of IkappaBs. J Leukoc Biol. 64:1998;667-674.
60. Li D., Saldeen T., Mehta J.L. γ-tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells. Biochem Biophys Res Commun. 259:1999;157-161.
61. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.